Closing the Chasm Between FDA, Payors, and Patients through Value-Based Care

Breakthrough medical products and technologies are coming to market faster than ever, many with high cost and uncertain benefit for all patients. Meanwhile, payors and providers are increasingly building care delivery models focused on improving quality and outcomes, while lowering health care spend. How do we protect expanded choices for patients and improve public health as America transitions to value based care?